OrthoSpineNews

MARCH 3, 2025

Spine Surgeon Dr. Frank Phillips Joins SST Board of Directors SAN ANTONIO, March 3, 2025 /PRNewswire/ — Spinal Stabilization Technologies, LLC (SST) has announced a significant milestone in its mission to revolutionize spinal care: the enrollment of the first U.S. Pierce Nunley completes the first U.S. PerQdisc Surgery.

Degenerative Disc Disease 52

Degenerative Disc Disease Patients Spine Clinic 52

OrthoSpineNews

APRIL 1, 2025

About the Study The clinical study involved 75 patients undergoing thoracolumbar fusion surgery to treat conditions including trauma, spinal stenosis, and degenerative disc disease. 2025) 196:123812. Key Study Findings: 3.4x lower rate of screw loosening (2.7% after one year 3.4 times lower than the 9.2% World Neurosurg.

Degenerative Disc Disease 40

Degenerative Disc Disease Clinic Spine Treatment 40

OrthoSpineNews

MAY 13, 2025

May 13, 2025 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. We have commenced a Phase 2 clinical trial using BRTX-100 to treat chronic lower back pain arising from degenerative disc disease. MELVILLE, N.Y.,

Degenerative Disc Disease 52

Degenerative Disc Disease Lower Back Pain Clinic Spine 52

OrthoSpineNews

JANUARY 7, 2025

January 7, 2025, NEW YORK–( BUSINESS WIRE )–Spine BioPharma, Inc., January 7, 2025, NEW YORK–( BUSINESS WIRE )–Spine BioPharma, Inc.,

Degenerative Disc Disease 52

Degenerative Disc Disease Spine Prevention Treatment 52

OrthoSpineNews

JUNE 13, 2025

June 13, 2025 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. This data was shared at the prestigious ISSCR 2025 Annual Meeting in Hong Kong by Francisco Silva, Vice President of Research and Development. We have also obtained U.S.

Degenerative Disc Disease 64

Degenerative Disc Disease Lower Back Pain Clinic Treatment 64

OrthoSpineNews

MAY 14, 2025

May 14, 2025 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. BioRestorative, BRTX or the Company) (NASDAQ: BRTX ) , a regenerative medicine innovator focused on stem cell-based therapies and products, today reported financial results for the first quarter ended March 31, 2025 and provided an update on its business.

Degenerative Disc Disease 52

Degenerative Disc Disease Lower Back Pain Neck Pain Treatment 52

OrthoSpineNews

MARCH 10, 2025

The results will be presented at the American Society of Pain and Neuroscience (ASPN) annual conference in July 2025, spotlighting Aurora Spines commitment to evidence-based innovation. CARLSBAD, Calif., CARLSBAD, Calif., We are incredibly proud to reach this milestone, said Trent Northcutt, President and CEO of Aurora Spine.

Degenerative Disc Disease 52

Degenerative Disc Disease Spine Clinic Musculoskeletal 52